Top Medical Stocks To Own For 2019

Self-described Tesla superfan Matthew Chan always wanted to meet some of the key people behind the electric car maker.

And when the cancer patient’s wish came true this week with a visit to the company’s factory in California, he got even more than he bargained for.

Not only did he go on a tour and meet Tesla’s top car designer, he also came face-to-face with CEO and co-founder Elon Musk.

It all started when Chan’s close friend Alan Miller shared a post on a couple of Tesla (TSLA) forums earlier this month.

“My best friend from medical school, Matthew Chan, is a 39 year old radiologist in Sacramento with 3 kids who was just diagnosed with stage 4 colon cancer,” he wrote.

The post added that Chan, who owns two Teslas, dreamed of meeting JB Straubel, the company’s chief technology officer, and Franz von Holzhausen, its lead designer.

“Of course, I wanted to meet Elon, but I was interested in also talking to the guys who Elon goes to and says, ‘I need this done,'” Chan told CNNMoney in a phone interview Thursday.

Top Medical Stocks To Own For 2019: CryoPort, Inc.(CYRX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on CryoPort (CYRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Press coverage about CryoPort (NASDAQ:CYRX) has been trending somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CryoPort earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave media coverage about the consumer goods maker an impact score of 46.4366918065987 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Ethan Ryder]

    CryoPort (NASDAQ:CYRX) posted its quarterly earnings results on Thursday. The consumer goods maker reported ($0.10) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.03), Briefing.com reports. The company had revenue of $4.02 million during the quarter, compared to the consensus estimate of $3.84 million. CryoPort had a negative return on equity of 47.36% and a negative net margin of 66.09%. The company’s revenue for the quarter was up 48.3% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.10) earnings per share.

Top Medical Stocks To Own For 2019: PennyMac Mortgage Investment Trust(PMT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Pennymac Mortgage Investment (NYSE:PMT) shares reached a new 52-week high and low on Monday . The company traded as low as $18.60 and last traded at $18.62, with a volume of 19306 shares changing hands. The stock had previously closed at $18.50.

  • [By Stephan Byrd]

    Pennymac Mortgage Investment (NYSE:PMT) – Equities researchers at Wedbush lifted their Q1 2019 earnings per share estimates for shares of Pennymac Mortgage Investment in a research note issued to investors on Thursday, May 10th. Wedbush analyst J. Weaver now anticipates that the real estate investment trust will post earnings per share of $0.36 for the quarter, up from their previous estimate of $0.34. Wedbush also issued estimates for Pennymac Mortgage Investment’s Q2 2019 earnings at $0.43 EPS, Q3 2019 earnings at $0.43 EPS, Q4 2019 earnings at $0.52 EPS and FY2019 earnings at $1.74 EPS.

Top Medical Stocks To Own For 2019: UnitedHealth Group Incorporated(UNH)

Advisors’ Opinion:

  • [By Paul Ausick]

    Before the opening bell Tuesday, Dow Jones Industrial Average component UnitedHealth Group Inc. (NYSE: UNH) is expected to report another solid quarter. After all, the company has beat analysts’ earnings estimate for eight straight quarters and revenues in six of those eight.

  • [By Chris Lange]

    UnitedHealth Group Inc. (NYSE: UNH) is scheduled to share its quarterly report on Tuesday as well. The consensus estimates are $2.91 in EPS on $54.8 billion in revenue. Shares were last seen at $224.28. The stock has a 52-week range of $164.96 to $250.79, and the consensus price target is $271.67.

  • [By JJ Kinahan]

    Going into earnings season, one school of thought was that investors might be concerned more about companies’ forward guidance in some cases than in Q1 results. There was worry that perhaps the recent market turmoil and fears of a possible trade war could dampen some S&P 500 firms’ expectations for what the near future might bring. It’s less than a week since earnings began and guidance could still represent a speed bump in coming weeks, but so far it hasn’t been a problem. For instance, UnitedHealth Group Inc. (NYSE: UNH) raised fiscal year guidance Tuesday, and Johnson & Johnson (NYSE: JNJ) raised its revenue guidance. In other signs of general good cheer, Goldman Sachs Group Inc. (NYSE: GS) raised its quarterly dividend, while Netflix (NFLX) reported big gains in subscriber growth. It’s still really early and things could change, but maybe some of those guidance fears could have been, shall we say, misguided? 

  • [By Paul Ausick]

    The second-best performer among the Dow index equities so far this year is Nike Inc. (NYSE: NKE), which is up 17.39%. That is followed by Microsoft Corp. (NASDAQ: MSFT), up 17.38%, UnitedHealth Group Inc. (NYSE: UNH), up 19.4%, and Boeing Co. (NYSE: BA), up 14.9%. Of the 30 Dow stocks, 11 have managed to post a gain to date in 2018.

  • [By Paul Ausick]

    The Dow stock posting the largest daily percentage gain ahead of the close Monday was UnitedHealth Group Inc. (NYSE: UNH) which traded up 1.67% at $242.25. The stock’s 52-week range is $166.65 to $250.79. Volume was about 15% below the daily average of around 3.5 million shares. The company had no specific news.

Top Medical Stocks To Own For 2019: Natural Health Trends Corp.(NHTC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

Top Medical Stocks To Own For 2019: Manitex International Inc.(MNTX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Manitex International Inc (NASDAQ:MNTX) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $12.95 and last traded at $12.61, with a volume of 655 shares changing hands. The stock had previously closed at $12.94.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Manitex International (MNTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Own For 2019: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

Leave a Reply

Your email address will not be published. Required fields are marked *